Ju‐Sheng Lin
- Molecular Biology
- Surgery top 10%
- Epidemiology top 10%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Hepatitis B Virus Studies (30 papers)Liver Disease Diagnosis and Treatment (13 papers)Hepatitis C virus research (11 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Ju‐Sheng Lin
62 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Molecular Biology 521
- Surgery 472
- Epidemiology 385
- Oncology 361
- Pulmonary and Respiratory Medicine 298
Countries citing papers authored by Ju‐Sheng Lin
This map shows the geographic impact of Ju‐Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Sheng Lin more than expected).
Fields of papers citing papers by Ju‐Sheng Lin
This network shows the impact of papers produced by Ju‐Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Sheng Lin. The network helps show where Ju‐Sheng Lin may publish in the future.
Co-authorship network of co-authors of Ju‐Sheng Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Sheng Lin. A scholar is included among the top collaborators of Ju‐Sheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Sheng Lin. Ju‐Sheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 78 | |
| 2 | 60 | |
| 3 | 29 | |
| 4 | 44 | |
| 5 | 11 | |
| 6 | 11 | |
| 7 | 4 | |
| 8 | 19 | |
| 9 | 19 | |
| 10 | 3 | |
| 11 | 28 | |
| 12 | 8 | |
| 13 | 1 | |
| 14 | 7 | |
| 15 | 1 | |
| 16 | [Relationship between death receptor 5 and apoptosis in hepatocellular carcinoma]. | 1 |
| 17 | 2 | |
| 18 | [Correlation between polymorphism of TaqI of ET-1 gene and cirrhotic portal hypertension]. | 1 |
| 19 | 7 | |
| 20 | [Inhibition of the replication of hepatitis B virus in vitro by a novel nucleoside analogue (beta-L-D4A)]. | 0 |
About Ju‐Sheng Lin
Ju‐Sheng Lin is a scholar working on Hepatology, Virology and Epidemiology, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (30 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis C virus research (11 papers). The work is most often cited by research in Hepatology (283 citations), Cancer Research (255 citations) and Gastroenterology (89 citations). Ju‐Sheng Lin has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Xingxing He, Ying Chang, Chuanrui Xu, Shuzhen Sun, Dong Xu, Yung‐Chi Cheng, Jiazhi Liao, Chung K. Chu, John C. Drach and Jiří Žemlička. Their work appears in journals such as PLoS ONE, Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.